Rocket One (RKTO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.51, -5.59% vs the prior close of $0.54.
- Volume 224.58K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RKTO slides 5.6% to $0.51, a 52-week low. Closed at $0.51, -5.59% vs the prior close of $0.54. Day range $0.50β$0.55, opened at $0.55.
RKTO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β RKTO slides 5.6% to $0.51, a 52-week low
- Closed at $0.51, -5.59% vs the prior close of $0.54. Day range $0.50β$0.55, opened at $0.55.
- Volume was 224.58K shares, 0.6x its 50-day average of 383.54K β lighter than usual.
- Price is -28.8% vs its 50-day average ($0.71) and -42.1% vs its 200-day average ($0.88).
- 52-week range $0.49β$2.45; today's close sits at 1% of that range, 79.3% below the 52-week high.
Oct 15, 2026 β RKTO rises 0.9% to $0.54
- Closed at $0.54, +0.94% vs the prior close of $0.53. Day range $0.51β$0.55, opened at $0.54.
- Volume was 185.70K shares, 0.5x its 50-day average of 385.24K β lighter than usual.
- Price is -25.2% vs its 50-day average ($0.72) and -38.9% vs its 200-day average ($0.88).
- 52-week range $0.49β$2.45; today's close sits at 2% of that range, 78.1% below the 52-week high.
Oct 14, 2026 β RKTO slides 6.8% to $0.53, a 6-month low, 3 down days in a row
- Closed at $0.53, -6.83% vs the prior close of $0.57. Day range $0.53β$0.57, opened at $0.57.
- Volume was 305.20K shares, 0.8x its 50-day average of 386.80K.
- Price is -26.4% vs its 50-day average ($0.72) and -39.6% vs its 200-day average ($0.88).
- 52-week range $0.49β$2.45; today's close sits at 2% of that range, 78.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β RKTO slides 4.8% to $0.57, a 6-month low
- Closed at $0.57, -4.83% vs the prior close of $0.60. Day range $0.56β$0.61, opened at $0.60.
- Volume was 602.60K shares, 1.6x its 50-day average of 381.13K.
- Price is -21.6% vs its 50-day average ($0.73) and -35.3% vs its 200-day average ($0.88).
- 52-week range $0.49β$2.45; today's close sits at 4% of that range, 76.7% below the 52-week high.
Oct 12, 2026 β RKTO slides 7.6% to $0.60, a 3-month low
- Closed at $0.60, -7.55% vs the prior close of $0.65. Day range $0.60β$0.65, opened at $0.65.
- Volume was 307.80K shares, 0.8x its 50-day average of 386.48K.
- Price is -18.1% vs its 50-day average ($0.73) and -32.2% vs its 200-day average ($0.89).
- 52-week range $0.49β$2.45; today's close sits at 6% of that range, 75.5% below the 52-week high.
Oct 9, 2026 β RKTO rises 0.5% to $0.65
- Closed at $0.65, +0.46% vs the prior close of $0.65. Day range $0.65β$0.68, opened at $0.66.
- Volume was 107.70K shares, 0.2x its 50-day average of 453.09K β lighter than usual.
- Price is -11.9% vs its 50-day average ($0.74) and -26.9% vs its 200-day average ($0.89).
- 52-week range $0.49β$2.45; today's close sits at 8% of that range, 73.5% below the 52-week high.
Oct 8, 2026 β RKTO slides 3.6% to $0.65, 3 down days in a row
- Closed at $0.65, -3.58% vs the prior close of $0.67. Day range $0.63β$0.68, opened at $0.67.
- Volume was 261.60K shares, 0.6x its 50-day average of 457.14K β lighter than usual.
- Price is -12.7% vs its 50-day average ($0.74) and -27.4% vs its 200-day average ($0.89).
- 52-week range $0.49β$2.45; today's close sits at 8% of that range, 73.6% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β RKTO slides 4.4% to $0.67
- Closed at $0.67, -4.42% vs the prior close of $0.70. Day range $0.67β$0.69, opened at $0.69.
- Volume was 197.90K shares, 0.4x its 50-day average of 465.51K β lighter than usual.
- Price is -9.7% vs its 50-day average ($0.74) and -24.9% vs its 200-day average ($0.89).
- 52-week range $0.49β$2.45; today's close sits at 9% of that range, 72.7% below the 52-week high.
Oct 6, 2026 β RKTO dips 1.3% to $0.70 on 2.7x normal volume
- Closed at $0.70, -1.27% vs the prior close of $0.71. Day range $0.69β$0.76, opened at $0.73.
- Volume was 1.21M shares, 2.7x its 50-day average of 450.13K β unusually heavy trading.
- Price is -5.8% vs its 50-day average ($0.74) and -21.6% vs its 200-day average ($0.89).
- 52-week range $0.49β$2.45; today's close sits at 11% of that range, 71.4% below the 52-week high.
Oct 5, 2026 β RKTO rises 1.7% to $0.71
- Closed at $0.71, +1.72% vs the prior close of $0.70. Day range $0.66β$0.73, opened at $0.69.
- Volume was 285.90K shares, 0.6x its 50-day average of 455.68K.
- Price is -4.8% vs its 50-day average ($0.75) and -20.8% vs its 200-day average ($0.90).
- 52-week range $0.49β$2.45; today's close sits at 11% of that range, 71.0% below the 52-week high.
Oct 2, 2026 β RKTO rises 1.0% to $0.70
- Closed at $0.70, +1.01% vs the prior close of $0.69. Day range $0.69β$0.72, opened at $0.71.
- Volume was 176.70K shares, 0.4x its 50-day average of 461.67K β lighter than usual.
- Price is -6.6% vs its 50-day average ($0.75) and -22.3% vs its 200-day average ($0.90).
- 52-week range $0.49β$2.45; today's close sits at 11% of that range, 71.5% below the 52-week high.
RKTO latest news & SEC filings
Every SEC filing by or about RKTO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 Β· Form PRE 14A β Preliminary proxy statement
Preliminary proxy statement
Sep 25, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.08 β Set shareholder nomination dates.
- Item 8.01 β Reported other events the company considers important.
Sep 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.83M (prior year -$2.20M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.19 (prior year -$0.17) (loss widened vs Jun 30, 2025)
Aug 11, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
- Item 8.01 β Reported other events the company considers important.
Jul 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Jul 31, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 21, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Jun 25, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Things to know before you trade RKTO
- How much it moves: over the last 20 sessions the average daily move was 3.19% (largest 7.6%). That is a volatile stock.
- Liquidity: about 337.22K shares (β$170.97K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.51 vs a range of $0.49β$2.45 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 25, 2026; 8-K Sep 22, 2026; 10-Q Aug 14, 2026.
- Share count: 24.90M shares outstanding (Aug 14, 2026), +87.8% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
RKTO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.55 | 0.55 | 0.50 | 0.51 | 224.58K |
| Oct 15, 2026 | 0.54 | 0.55 | 0.51 | 0.54 | 200.20K |
| Oct 14, 2026 | 0.57 | 0.57 | 0.53 | 0.53 | 305.20K |
| Oct 13, 2026 | 0.60 | 0.61 | 0.56 | 0.57 | 602.60K |
| Oct 12, 2026 | 0.65 | 0.65 | 0.60 | 0.60 | 307.80K |
| Oct 9, 2026 | 0.66 | 0.68 | 0.65 | 0.65 | 107.70K |
| Oct 8, 2026 | 0.67 | 0.68 | 0.63 | 0.65 | 261.60K |
| Oct 7, 2026 | 0.69 | 0.69 | 0.67 | 0.67 | 197.90K |
| Oct 6, 2026 | 0.73 | 0.76 | 0.69 | 0.70 | 1.21M |
| Oct 5, 2026 | 0.69 | 0.73 | 0.66 | 0.71 | 285.90K |
| Oct 2, 2026 | 0.71 | 0.72 | 0.69 | 0.70 | 176.70K |
| Oct 1, 2026 | 0.71 | 0.73 | 0.69 | 0.69 | 123.60K |
| Sep 30, 2026 | 0.71 | 0.75 | 0.71 | 0.71 | 145.00K |
| Sep 29, 2026 | 0.73 | 0.74 | 0.71 | 0.73 | 115.70K |
| Sep 28, 2026 | 0.75 | 0.77 | 0.73 | 0.74 | 204.60K |
| Sep 25, 2026 | 0.77 | 0.80 | 0.75 | 0.77 | 138.90K |
| Sep 24, 2026 | 0.74 | 0.77 | 0.73 | 0.76 | 255.40K |
| Sep 23, 2026 | 0.77 | 0.79 | 0.74 | 0.75 | 280.90K |
| Sep 22, 2026 | 0.74 | 0.84 | 0.73 | 0.78 | 1.28M |
| Sep 21, 2026 | 0.81 | 0.83 | 0.75 | 0.75 | 318.40K |
About Rocket One
Rocket One (RKTO) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in HOBOKEN, NJ. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1711786.
RKTO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Christopher Michael Camarra | Director | May 28, 2026 |
| Robb Knie | CEO and President | May 28, 2026 |
| Wayne Linsley | Director | May 28, 2026 |
| Jeff Pavell | Director | May 28, 2026 |
| David Sarnoff | Director | May 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robb Knie | CEO and President | May 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
RKTO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-12.47M | -0.90 | $-9.80M |
| Dec 31, 2024 | β | $-8.19M | -1.28 | $-6.98M |
| Dec 31, 2023 | β | $-8.11M | -2.38 | $-8.45M |
| Dec 31, 2022 | β | $-11.37M | -9.50 | $-9.30M |
| Dec 31, 2021 | β | $-14.31M | -16.02 | $-12.09M |
Latest balance sheet: total assets $9.58M, total liabilities $1.38M, cash $7.89M (as of Jun 30, 2026).
RKTO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RKTO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.